Semaglutide, the active ingredient in Wegovy and Ozempic, has gained popularity for its effectiveness in managing weight loss and type 2 diabetes
One to two weeks after the operation, feeding experiments and GTTs were performed
1 This insulin secretion causes an overall decrease in blood sugar levels, reduces the production of glucagon, which prevents the release of glucose storage from the liver, and induces a satiety response that elevates insulin sensitivity and causes weight loss
Now, with the FDA already removing Ozempic, Mounjaro, and Wegovy from its shortage list, the compounded versions of GLP-1 drugs will no longer be a viable option
Serious allergic responses, pancreatitis, gallbladder problems, hypoglycemia, kidney damage, and possible thyroid troubles are rare but possible side effects
Make sure you're getting enough essential vitamins and minerals to support healthy hair growth